日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinicopathological and functional evaluation of replication protein A in epithelial ovarian cancers: A target validation study.

卵巢上皮癌中复制蛋白 A 的临床病理学和功能评价：靶点验证研究。

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2026.102709
Algethami Mashael, Sheha Amera, Singhania Nehal, Alqahtani Shatha, Shoqafi Ahmed, Tosun Çağla, Spicer Jake, Toss Michael S, Alblihy Adel, Lashen Ayat, Jeyapalan Jennie N, Mongan Nigel P, Rakha Emad A, Madhusudan Srinivasan
肿瘤
发表日期：2026
文献求助 收藏

From desert flora to cancer therapy: systematic exploration of multi-pathway mechanisms using network pharmacology and molecular modeling approaches

从沙漠植物到癌症治疗：利用网络药理学和分子建模方法系统地探索多通路机制

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1345415
Alblihy, Adel
信号转导
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers

揭示复制蛋白 A (RPA) 异三聚体复合物在乳腺癌中的临床病理学和功能意义

期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-023-00524-3
Mashael Algethami, Michael S Toss, Corinne L Woodcock, Chandar Jaipal, Juliette Brownlie, Ahmed Shoqafi, Adel Alblihy, Katia A Mesquita, Andrew R Green, Nigel P Mongan, Jennie N Jeyapalan, Emad A Rakha, Srinivasan Madhusudan
肿瘤
乳腺癌
发表日期：2023
文献求助 收藏

Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade

通过 MRE11 阻断选择性杀死 BRCA2 缺陷卵巢癌细胞

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms241310966
Adel Alblihy, Reem Ali, Mashael Algethami, Alison A Ritchie, Ahmed Shoqafi, Shatha Alqahtani, Katia A Mesquita, Michael S Toss, Paloma Ordóñez-Morán, Jennie N Jeyapalan, Lodewijk Dekker, Martina Salerno, Edgar Hartsuiker, Anna M Grabowska, Emad A Rakha, Nigel P Mongan, Srinivasan Madhusudan
肿瘤
卵巢癌
肿瘤细胞
WB
发表日期：2023
文献求助 收藏

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers

靶向 Mre11 可克服铂类耐药性并在 XRCC1 缺陷型上皮性卵巢癌中诱导合成致死

期刊:npj Precision Oncology
影响因子:6.8
doi:10.1038/s41698-022-00298-0
Adel Alblihy, Reem Ali, Mashael Algethami, Ahmed Shoqafi, Michael S Toss, Juliette Brownlie, Natalie J Tatum, Ian Hickson, Paloma Ordonez Moran, Anna Grabowska, Jennie N Jeyapalan, Nigel P Mongan, Emad A Rakha, Srinivasan Madhusudan
肿瘤
卵巢癌
发表日期：2022
文献求助 收藏

Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers

连接酶1是铂类耐药性的预测因子，阻断连接酶1在XRCC1缺陷型上皮性卵巢癌中具有合成致死性。

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.51456
Ali, Reem; Alabdullah, Muslim; Algethami, Mashael; Alblihy, Adel; Miligy, Islam; Shoqafi, Ahmed; Mesquita, Katia A; Abdel-Fatah, Tarek; Chan, Stephen Yt; Chiang, Pei Wen; Mongan, Nigel P; Rakha, Emad A; Tomkinson, Alan E; Madhusudan, Srinivasan
肿瘤
RCC1
肿瘤免疫
卵巢癌
XRCC1
发表日期：2021
文献求助 收藏

Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers

揭示 MRE11-RAD50-NBS1 复合物在散发性乳腺癌中的临床病理学意义

期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-021-00350-5
Adel Alblihy #, Ahmed Shoqafi #, Michael S Toss, Mashael Algethami, Anna E Harris, Jennie N Jeyapalan, Tarek Abdel-Fatah, Juliette Servante, Stephen Y T Chan, Andrew Green, Nigel P Mongan, Emad A Rakha, Srinivasan Madhusudan
肿瘤
乳腺癌
发表日期：2021
文献求助 收藏

Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers

临床病理学和功能评估表明 NBS1 是上皮性卵巢癌铂耐药性的预测因子

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines9010056
Adel Alblihy, Muslim L Alabdullah, Reem Ali, Mashael Algethami, Michael S Toss, Nigel P Mongan, Emad A Rakha, Srinivasan Madhusudan
肿瘤
卵巢癌
发表日期：2021
文献求助 收藏

FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers

FEN1 阻断对上皮性卵巢癌的铂化疗增敏和合成致死率的影响

期刊:Cancers
影响因子:
doi:10.3390/cancers13081866
Katia A Mesquita, Reem Ali, Rachel Doherty, Michael S Toss, Islam Miligy, Adel Alblihy, Dorjbal Dorjsuren, Anton Simeonov, Ajit Jadhav, David M Wilson 3rd, Ian Hickson, Natalie J Tatum, Emad A Rakha, Srinivasan Madhusudan
肿瘤
卵巢癌
发表日期：2021
文献求助 收藏

PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers

PARP1 阻断对缺乏 XRCC1 的散发性上皮性卵巢癌具有综合致死性

期刊:Cancer Letters
影响因子:9.1
doi:10.1016/j.canlet.2019.10.035
Reem Ali, Muslim Alabdullah, Adel Alblihy, Islam Miligy, Katia A Mesquita, Stephen Yt Chan, Paul Moseley, Emad A Rakha, Srinivasan Madhusudan
肿瘤
卵巢癌
发表日期：2020
文献求助 收藏